Ledger.Open graph →
SEC Form D · Amendment · filed September 21, 2016

Compass Therapeutics LLC

Offering
$170.2M
Sold
$46.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Thomas Schuetz · HANOVER, NHExec · Director · PromoterCarl Gordon · SAN FRANCISCO, CADirectorSteve Tregay · Cambridge, MADirectorStephen Squinto · Woodbridge, CTDirectorCarl Gordon · Encinitas, CADirectorPhilip Ferneau · Portland, MEDirectorErrik Anderson · Bedford, NHExec · Director · PromoterBen Auspitz · Bozeman, MTDirectorStephen Squinto · HANOVER, NHDirectorThomas Schuetz · Montreal, Quebec, CanadaExec · Director · PromoterCarl Gordon · CAMBRIDGE, MADirectorPhilip Ferneau · Portland, MEDirectorErrik Anderson · Bedford, NHExec · Director · PromoterSteve Tregay · Cambridge, MADirectorBen Auspitz · DURHAM, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗